Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Absci Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ABSI
Nasdaq
2834
www.absci.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Absci Corporation
Absci to Participate in Upcoming Investor Conferences
- May 20th, 2025 6:00 am
Absci First Quarter 2025 Earnings: Beats Expectations
- May 15th, 2025 5:12 am
Absci Corp (ABSI) Q1 2025 Earnings Call Highlights: Transition to Clinical Stage and Strong ...
- May 14th, 2025 1:17 am
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
- May 13th, 2025 3:30 pm
Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
- May 13th, 2025 2:05 pm
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
- May 13th, 2025 2:01 pm
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
- Apr 14th, 2025 2:05 pm
March 2025 Penny Stocks Worth Watching
- Mar 19th, 2025 11:05 am
Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ...
- Mar 19th, 2025 1:03 am
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
- Mar 18th, 2025 2:05 pm
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025
- Mar 4th, 2025 2:05 pm
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 4th, 2025 2:00 pm
Absci to Participate in the KeyBanc Capital Markets Healthcare Forum
- Mar 4th, 2025 6:00 am
Why Absci Corporation (ABSI) is Skyrocketing So Far in 2025
- Mar 1st, 2025 3:19 pm
Absci to Participate in the TD Cowen 45th Annual Health Care Conference
- Feb 18th, 2025 6:00 am
Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy?
- Feb 12th, 2025 7:24 am
Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham
- Jan 24th, 2025 9:54 am
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
- Jan 22nd, 2025 11:22 am
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
- Jan 22nd, 2025 6:00 am
Absci Corporation (ABSI): AI in Biopharma Discovery
- Jan 17th, 2025 11:54 am
Scroll